Performance of Implantable Cardiac Rhythm Management Devices |
| |
| Authors: | MICHAEL BILITCH ROBERT G. HAUSER BERNARD S. GOLDMAN JAMES D. MALONEY J. WARREN HARTHORNE SEYMOUR FURMAN VIGTOR PARSONNET |
| |
| Affiliation: | Pacemaker Center, University of Southern California School of Medicine, 1420 San Pablo Street, Los Angeles, CA 90033 USA (Michael Bilitch, M.D.);Rush-Presbyterian/St. Luke's Medical Center, 1753 West Congress Parkway, Chicago, Illinois 60612 USA (Robert G. Hauser, M.D.);Toronto General Hospital, 101 College Street, Toronto, Ontario, M5G 1L7, Canada (Bernard S. Goldman, M.D.);The Cleveland Clinic Foundation. 9500 Euclid Avenue, Cleveland, OH 44106 USA (James D. Maloney, M.D.);Massachusetts General Hospital, 14 Fruit Street, Boston, Massachusetts 02114 USA (J. Warren Harthorne, M.D.);Montefiore Medical Center, 111 E. 210th Street, Bronx, New York 10467 USA (Seymour Furman, M.D.);Pacemaker Center, Inc., Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, New Jersey 07112 USA (Victor Parsonnel, M.D.) |
| |
| Abstract: | Our data represent use, follow-up, and management decisions from seven independently functioning centers and most importantly, actuarial survival of ICRMDs that have been implanted for sufficient time period to allow assessment of time versus failure. General patterns of possible target durations for adequate performance for present or future generations of similar clinical devices may be suggested by the data that we have presented. However, it would be inappropriate to conclude from these data that any presently implanted ICRMD would have a particular functional reliability. These data, furthermore, only summarized device hardware performance and cannot and must not be used to determine either short-term or long-term individual patient status, management, or outcome. |
| |
| Keywords: | |
|
|
